Neboglamine
Neboglamine (CR-2249; XY-2401) is a modulator for N-methyl-D-aspartate (NMDA) receptor. Neboglamine increases the levels of fos-like immunoreactivity (FLI) -positive cells in the prefrontal cortex, nucleus accumbens, and lateral septal nucleus in rat models, .restores NMDA (HY-17551) -mediated neurotransmitter release, and inhibits phencyclidine-induced hyperlocomotion[1].
Product Specifications
CAS Number
[163000-63-3]
Product Name Alternative
CR-2249; XY-2401
UNSPSC
12352211
Hazard Statement
H302
Target
IGluR
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel; Neuronal Signaling
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/neboglamine.html
Smiles
OC(CC[C@H](N)C(NC1CCC(C)(CC1)C)=O)=O
Molecular Formula
C13H24N2O3
Molecular Weight
256.34
Precautions
P264-P270-P330-P501
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Browse additional items from our catalog
RND2 (Rho-related GTP-binding Protein RhoN, RhoN, ARHN, Rho Family GTPase 2, Rho-related GTP-binding Protein Rho7, RHO7) APC
RND2 (Rho-related GTP-binding Protein RhoN, RhoN, ARHN, Rho Family GTPase 2, Rho-related GTP-binding Protein Rho7, RHO7) APC
Bcl11a sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 3)
